SCIENCE IN THE SERVICE OF MEDICINE Trademark Information

Trademark by Vaccinex Inc.

Adjuvants for medical purposes; Reagents for medical use; Therapeutic pharmaceutical for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders; Vaccine adjuvants; Vaccines; Adjuvants for use with vaccines; Clinical medical reagents; Human vaccine preparations; Therapeutic vaccines

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: 1/1/1999
First Use In Commerce: 1/1/1999
General Information
Word mark: SCIENCE IN THE SERVICE OF MEDICINE
Status/Status Date:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
2/12/2020
Serial Number: 88125908
Filing Date: 9/20/2018
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Adjuvants for medical purposes; Reagents for medical use; Therapeutic pharmaceutical for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders; Vaccine adjuvants; Vaccines; Adjuvants for use with vaccines; Clinical medical reagents; Human vaccine preparations; Therapeutic vaccines
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner:
Vaccinex Inc.
New York, NY 10022
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
canady + lortz LLP
Suite 508
3701 WILSHIRE BLVD
Los Angeles CA 90010
Current Status:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
2/12/2020
Correspondent Search:
KAREN S. CANADY is a correspondent of SCIENCE IN THE SERVICE OF MEDICINE trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on